CHICAGO, May 16, 2012/PRNewswire/
-- Allscripts Healthcare Solutions, Inc. (Allscripts -
NASDAQ: MDRX) today announced that its Board of Directors
has appointed Paul M. Black, former Chief
Operating Officer of Cerner Corporation, and The Hon.
Robert J. Cindrich(Ret.), former Senior Vice
President and Chief Legal Officer for the University
of PittsburghMedical Center (UPMC), as directors,
effective immediately. Mr. Black will serve on the
Board's Compensation Committee and Mr. Cindrich will
serve on the Board's Audit Committee. The Board is now
set at seven directors.
"We are pleased to add two new independent directors
of such a high caliber," said Chairman Dennis
Chookaszian. "Paul and Robert bring an
outstanding combination of operational, governance and
healthcare industry experience, which make them excellent
additions to our Board. We believe their
contributions and insights will be invaluable as the
Company executes on its plan to deliver value for our
customers, drive long-term growth and build shareholder
value."
"Allscripts has well-respected solutions, a broad and
unique client base, and a compelling vision for an open,
connected, community-based, individually coordinated level
of care," said Paul Black. "I'm
optimistic about the market opportunity before us and
looking forward to collaborating with the Board and
management to execute the Company's plan to enhance the
client experience, improve healthcare outcomes and deliver
value for customers, team members and shareholders."
Robert Cindrichsaid, "Allscripts has an
exciting opportunity to build on its leading position in
the growing market for healthcare information technology.
Having spent years with one of the largest and most
respected integrated delivery networks in the world, I
believe I can bring a unique client perspective to
management and the Board. I look forward to working with my
fellow directors and drawing upon my experience to help the
Board and management team implement the Company's
strategic plans."
Allscripts' incumbent directors, including Messrs.
Black and Cindrich, will stand for re-election at the
Annual Meeting of Stockholders on June 15,
2012. Stockholders of record as of the close of
business on April 24, 2012, will be entitled
to vote. Information on all director nominees can be
found in the Company's proxy statement, which has been
filed today with the Securities and Exchange Commission and
will be mailed to all stockholders of record.
Paul M. Black
Mr. Black currently serves as Operating Executive of
Genstar Capital, LLC, a private equity firm, and as Senior
Advisor at New Mountain Finance Corporation, an investment
management company. Prior to joining Genstar, Mr. Black
spent over 13 years with Cerner Corporation and retired as
its Chief Operating Officer in 2007 after helping build it
into a $1.5 billioncompany. He also served as
Chief Sales Officer and played an instrumental role in the
company's double digit organic growth. Prior to Cerner,
Mr. Black was with IBM from 1982 to 1994 in a number of
senior sales and professional services leadership
positions.
Mr. Black was most recently elected to the Board of
Directors of Haemonetics Corporation, a global healthcare
company dedicated to providing innovative blood management
solutions. He also serves on the boards of Saepio, Inc.,
Truman Medical Centers, and Genstar portfolio company,
Netsmart Technologies. In addition, he has served as a
Director with several New Mountain portfolio companies. Mr.
Black received a B.S. from Iowa State
Universityand an M.B.A. from the University of
Iowa.
Robert J. Cindrich
Mr. Cindrich is the former senior vice president and chief
legal officer for UPMC, a position he held from 2004 to
2010, and currently serves as senior advisor to the Office
of the President of UPMC. In that role, he advises
the chief executive officer, UPMC's senior leadership,
and the Board of Directors on key governance and strategic
issues. Prior to UPMC, Mr. Cindrich served as a judge
of the United States District Court for the Western
District of Pennsylvaniafor 10 years. Prior to
that appointment, he was active as an attorney in both
government and private practice. His government practice
includes serving as chair of the Pennsylvania Legislative
Reapportionment Commission, 1992-93; United States District
Attorney, Western PennsylvaniaDistrict,
1978-81; and Assistant District Attorney, Allegheny
County, 1970-72. While in private practice, he
served as defense counsel in business and commercial
litigation.
Mr. Cindrich currently serves as a director of Mylan Inc.,
a leading generics and specialty pharmaceutical
company. He is a graduate of the University of
PittsburghSchool of Law and served in the
United StatesArmy Reserves and the United States Air
Force Reserves.
About Allscripts
Allscripts (NASDAQ:
MDRX) delivers the insights that healthcare providers
require to generate world-class outcomes. The company's
Electronic Health Record, practice management and other
clinical, revenue cycle, connectivity and information
solutions create a Connected Community of Health™ for
physicians, hospitals and post-acute organizations.
To learn more about Allscripts, please visit www.allscripts.com, Twitter, YouTube and
It Takes A
Community: The
Allscripts Blog.
Forward-Looking Statements
This press release contains forward-looking statements
within the meaning of the federal securities laws.
Statements regarding future events or developments, our
future performance, as well as management's
expectations, beliefs, intentions, plans, estimates or
projections relating to the future are forward-looking
statements with the meaning of these laws. These
forward-looking statements are subject to a number of risks
and uncertainties, some of which are outlined below. As a
result, no assurances can be given that any of the events
anticipated by the forward-looking statements will
transpire or occur, or if any of them do so, what impact
they will have on our results of operations or financial
condition. Such risks, uncertainties and other factors
include, among other things: the possibility that the
expected synergies, efficiencies and cost savings of the
merger with Eclipsys Corporation ("Eclipsys")
will not be realized, or will not be realized within the
expected time period; potential difficulties or delays in
achieving platform and product integration and the
connection and movement of data among hospitals,
physicians, patients and others; the risk that the
Allscripts and Eclipsys businesses will not be integrated
successfully; competition within the industries in which we
operate; failure to achieve certification under the Health
Information Technology for Economic and Clinical Health Act
could result in increased development costs, a breach of
some customer obligations and could put us at a competitive
disadvantage in the marketplace; the volume and timing of
systems sales and installations, the length of sales cycles
and the installation process and the possibility that our
products will not achieve or sustain market acceptance; the
timing, cost and success or failure of new product and
service introductions, development and product upgrade
releases; competitive pressures including product
offerings, pricing and promotional activities; our ability
to establish and maintain strategic relationships;
undetected errors or similar problems in our software
products; the outcome of any legal proceeding that has been
or may be instituted against us; compliance with existing
laws, regulations and industry initiatives and future
changes in laws or regulations in the healthcare industry,
including possible regulation of our software by the U.S.
Food and Drug Administration; the possibility of
product-related liabilities; our ability to attract and
retain qualified personnel; the implementation and speed of
acceptance of the electronic record provisions of the
American Recovery and Reinvestment Act of 2009; maintaining
our intellectual property rights and litigation involving
intellectual property rights; risks related to third-party
suppliers and our ability to obtain, use or successfully
integrate third-party licensed technology; and breach of
our security by third parties. See our Annual Report on
Form 10-K for 2011 and other public filings with the SEC
for a further discussion of these and other risks and
uncertainties applicable to our business. The statements
herein speak only as of their date and we undertake no duty
to update any forward-looking statement whether as a result
of new information, future events or changes in
expectations.
SOURCE Allscripts Healthcare Solutions, Inc.
Investors: Seth Frank, +1-312-506-1213,
seth.frank@allscripts.com; or Media: Ariana Nikitas,
+1-312-506-1236, ariana.nikitas@allscripts.com
Recommend:
